A training for health care workers to integrate hepatitis B care and treatment into routine HIV care in a high HBV burden, poorly resourced region of Uganda: the '2for1' project.


Journal

BMC medical education
ISSN: 1472-6920
Titre abrégé: BMC Med Educ
Pays: England
ID NLM: 101088679

Informations de publication

Date de publication:
20 Apr 2022
Historique:
received: 29 03 2021
accepted: 11 03 2022
entrez: 21 4 2022
pubmed: 22 4 2022
medline: 23 4 2022
Statut: epublish

Résumé

The "2for1" project is a demonstration project to examine the feasibility and effectiveness of HBV care integrated into an HIV clinic and service. An initial phase in implementation of this project was the development of a specific training program. Our objective was to describe key features of this integrated training curriculum and evaluation of its impact in the initial cohort of health care workers (HCWs). A training curriculum was designed by experts through literature review and expert opinion. Key distinctive features of this training program (compared to standard HBV training provided in the Government program) were; (i) Comparison of commonalities between HIV and HBV (ii) Available clinic- and community-level infrastructure, and the need to strengthen HBV care through integration (iii) Planning and coordination of sustained service integration. The training was aided by a power-point guided presentation, question and answer session and discussion, facilitated by physicians and hepatologists with expertise in viral hepatitis. Assessment approach used a self-administered questionnaire among a cohort of HCWs from 2 health facilities to answer questions on demographic information, knowledge and attitudes related to HBV and its prevention, before and after the training. Knowledge scores were generated and compared using paired t- tests. A training curriculum was developed and delivered to a cohort of 44 HCWs including medical and nursing staff from the two project sites. Of the 44 participants, 20 (45.5%) were male, average age (SD) was 34.3 (8.3) with an age range of 22-58 years. More than half (24, 54.5%) had been in service for fewer than 5 years. Mean correct knowledge scores increased across three knowledge domains (HBV epidemiology and transmission, natural history and treatment) post-intervention. However, knowledge related to diagnosis and prevention of HBV did not change. A structured HBV education intervention conducted as part of an HIV/HBV care integration training for health care workers yielded improved knowledge on HBV and identified aspects that require further training. This approach may be replicated in other settings, as a public health strategy to heighten HBV elimination efforts.

Identifiants

pubmed: 35443646
doi: 10.1186/s12909-022-03329-3
pii: 10.1186/s12909-022-03329-3
pmc: PMC9020110
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

297

Subventions

Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Gilead Sciences
ID : ISR-UG-10468

Informations de copyright

© 2022. The Author(s).

Références

Asia Pac J Oncol Nurs. 2016 Oct-Dec;3(4):344-351
pubmed: 28083551
BMC Public Health. 2019 Jul 26;19(1):1004
pubmed: 31349838
J Lab Physicians. 2018 Oct-Dec;10(4):374-379
pubmed: 30498306
Asian Pac J Cancer Prev. 2013;14(8):4705-9
pubmed: 24083730
Am J Trop Med Hyg. 2017 Feb 8;96(2):400-404
pubmed: 27920392
Am J Gastroenterol. 2015 Nov;110(11):1629-31
pubmed: 26618430
J Community Health. 2010 Jun;35(3):325-35
pubmed: 20135208
JAMA Oncol. 2017 Dec 1;3(12):1683-1691
pubmed: 28983565
Lancet. 2015 Oct 17;386(10003):1546-55
pubmed: 26231459
Lancet Infect Dis. 2016 Dec;16(12):1409-1422
pubmed: 27615026
BMC Infect Dis. 2018 Jul 9;18(1):315
pubmed: 29986658
BMC Med Educ. 2016 Mar 08;16:81
pubmed: 26952079
Open Forum Infect Dis. 2017 Nov 17;5(1):ofx252
pubmed: 29354656
PLoS One. 2019 Oct 14;14(10):e0223733
pubmed: 31609983
BMC Health Serv Res. 2017 Apr 5;17(1):254
pubmed: 28381257
BMC Health Serv Res. 2019 Oct 22;19(1):736
pubmed: 31640692
BMC Public Health. 2010 Feb 25;10:98
pubmed: 20184740
Prev Med. 2013 Jan;56(1):53-8
pubmed: 23159302
Prev Chronic Dis. 2014 Feb 06;11:130258
pubmed: 24503341
J Assoc Physicians India. 2018 Dec;66(12):27-30
pubmed: 31315320
Ann Med Health Sci Res. 2013 Oct;3(4):551-8
pubmed: 24380007
J Immigr Minor Health. 2009 Aug;11(4):281-90
pubmed: 17990118
BMC Res Notes. 2016 Aug 19;9(1):410
pubmed: 27543117
BMC Res Notes. 2015 Aug 29;8:384
pubmed: 26319021
Infect Dis Health. 2020 Feb;25(1):50-59
pubmed: 31767401
BMC Public Health. 2019 Nov 29;19(1):1597
pubmed: 31783744
BMC Fam Pract. 2016 Aug 04;17:104
pubmed: 27488823
J Community Health. 2009 Jun;34(3):165-72
pubmed: 19127416
Am J Trop Med Hyg. 2016 May 4;94(5):1100-2
pubmed: 26928835
BMC Med Educ. 2014 Nov 21;14:244
pubmed: 25412798
Gastroenterol Nurs. 2017 Mar/Apr;40(2):143-150
pubmed: 28362662
Lancet. 2016 Sep 10;388(10049):1081-1088
pubmed: 27394647
Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):782-91
pubmed: 23613027
Lancet Gastroenterol Hepatol. 2017 Dec;2(12):900-909
pubmed: 29132759
Can J Gastroenterol. 2012 Sep;26(9):597-602
pubmed: 22993729
Afr Health Sci. 2009 Jun;9(2):98-108
pubmed: 19652743
Wellcome Open Res. 2018 Mar 16;3:29
pubmed: 30483598

Auteurs

Joan Nankya-Mutyoba (J)

Department of Epidemiology & Biostatistics, School of Public Health, Makerere University College of Health Sciences, P.O. Box 7072, Kampala, Uganda. eron.jm@hotmail.com.

David Ejalu (D)

Department of Epidemiology & Biostatistics, School of Public Health, Makerere University College of Health Sciences, P.O. Box 7072, Kampala, Uganda.

Claude Wandera (C)

Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.

Rachel Beyagira (R)

Program On Viral Hepatitis, Ministry of Health, Kampala, Uganda.

Jacinto Amandua (J)

Program On Viral Hepatitis, Ministry of Health, Kampala, Uganda.

Emmanuel Seremba (E)

Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.

Kaggwa Mugagga (K)

Global Hepatitis Program, WHO, Geneva, Switzerland.

Andrew Kambugu (A)

Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.

Alex Muganzi (A)

Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.

Philippa Easterbrook (P)

Global Hepatitis Program, WHO, Geneva, Switzerland.

Ponsiano Ocama (P)

Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH